SHANGHAI, April 22, 2025 /PRNewswire/ -- As an authorized distributor, Mouser Electronics, Inc. is focused on the rapid introduction of new products and technologies, giving customers an edge and helping speed time to market. Over 1,200 semiconductor and electronic component manufacturer brands count on Mouser to help them introduce their products into the global marketplace. Mouser's customers can expect 100% certified, genuine products that are fully traceable from each manufacturer.
Last quarter, Mouser launched more than 8,000 part numbers ready for shipment. Some of the products introduced by Mouser from January through March 2025 include:
To see more of the New Product Insider highlights, go to https://info.mouser.com/new_products/https://www.mouser.com/newproductinsider.
For more Mouser news, visit https://www.mouser.com/newsroom/.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Mouser Electronics New Product Insider: Over 8,000 New Parts Added in First Quarter of 2025
KUALA LUMPUR, Malaysia, May 2, 2025 /PRNewswire/ -- As Southeast Asia's pharmaceutical industry rapidly evolves—driven by regulatory harmonization, innovation, and growing healthcare demand—CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakthroughs, and unlock business opportunities across the ASEAN region.
Taking place for the first time in Kuala Lumpur, Malaysia, from 16–18 July 2025, the event will bring together 8,000+ professionals, 400+ global exhibitors, and curated buyers from across Asia and beyond—positioning it as the region's most impactful pharma event.
Unlock Growth Across ASEAN's Pharma Markets
From Indonesia, Thailand, Vietnam, the Philippines to Malaysia, Southeast Asia is one of the world's most dynamic pharmaceutical regions. Governments are investing in local manufacturing, reforming regulatory systems, and opening doors to international partnerships.
Malaysia, as this year's host, plays a central role in this growth. [1]The country's pharmaceutical market is expected to rise from RM11.2 billion in 2022 to RM15.5 billion by 2027, supported by the New Industrial Master Plan (NIMP) 2030, which incentivizes the production of APIs, biologics, and vaccines.
[2] Strategically located between Singapore and Indonesia, Malaysia offers streamlined access to regional distributors, CDMOs, and packaging partners—making Kuala Lumpur a strategic gateway to ASEAN-wide expansion.
Source: 1. MIDA, MITI Malaysia
2. ASEAN Pharmaceutical Industry Report
At CPHI South East Asia 2025, you'll be able to:
Event Highlights
Venue: MITEC, Kuala Lumpur
Dates: 16–18 July 2025
Explore more at: https://www.cphi.com/sea
Register to visit at: https://cphisea.imasia-passport.com/
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
CPHI South East Asia 2025: Your gateway to ASEAN's expanding pharmaceutical landscape
